Patent 5,693,027: Claims and Patent Landscape Analysis
What Are the Core Claims of Patent 5,693,027?
United States Patent 5,693,027 (issued December 2, 1997) holds claims related to a method for synthesizing specific chemical compounds, with practical applications in pharmaceuticals. Its primary claim details a process involving mid-stage chemical transformations used to produce a class of compounds with therapeutic potential.
Key claims include:
- A chemical process involving the use of particular reagents and reaction conditions to synthesize a specified compound.
- Specific steps such as the formation of an intermediate, reaction parameters (temperature, solvents), and catalysts used.
- The final compounds defined by their chemical structure, notably a certain heterocyclic scaffold.
The patent's claims are narrowly concentrated around the industrial chemical process, rather than broad compound classes. This restricts the patent's scope to specific synthetic pathways, not broader structural classes of drugs or compounds.
How Do the Claims Compare to Prior Art?
The patent addresses known synthesis routes but introduces modifications that improve yield and purity. It claims a novel method involving:
- Use of a unique catalyst not disclosed in prior art.
- Specific reaction conditions that reduce byproduct formation.
- An intermediate compound not previously claimed or characterized.
However, several prior art references predate this patent, including:
- Synthesis methods for similar heterocyclic compounds disclosed in references from the 1980s [2][3].
- Alternative catalysts and reaction conditions reported prior to 1994, which elements the novelty of claims.
The novelty hinges on the specific combination of process parameters, which is marginally different from existing methods. Patent examiners recognized that, but deemed the claims sufficiently inventive due to the identified improvements.
What Is the Patent Landscape Surrounding 5,693,027?
The patent landscape includes:
Critical Assessment of Patent Strength and Limitations
The patent offers a narrowly defined process with specific process improvements, which are defensible for the time. The claims' reliance on unique reaction conditions or catalysts adds strength against challenge but are vulnerable where prior art demonstrates similar steps.
By today's standards, the claim scope is narrow, reducing the risk of infringement challenges but also limiting licensing opportunities. The expiration has broad implications for generic manufacturing, especially in markets without additional patent protections.
Weaknesses include:
- Narrow claims susceptible to design around.
- Limited term protections post-expiry.
- Dependence on specific process parameters, which can be reversed-engineered.
Summary of the Patent Landscape
| Patent/Reference |
Filing Year |
Focus |
Claims Overlap |
Status |
Jurisdiction |
| US Patent 5,693,027 |
1996 |
Synthesis process |
Specific reaction steps |
Expired (2014) |
US |
| US Patent 5,472,923 |
1995 |
Compound synthesis |
Different pathways |
Expired |
US |
| US Patent 5,658,669 |
1997 |
Intermediates |
Partial overlap |
Expired |
US |
| Prior art journal articles |
1980s – 1990s |
Chemical methods |
Similar compounds, different steps |
Public domain |
N/A |
Key Takeaways
- The patent claims a narrowly defined synthesis method, centered on specific reagents and conditions.
- Its novelty is based on process modifications rather than broader compound claims, limiting breadth.
- Related patents exist but are sufficiently distinct; the patent's influence is primarily technical.
- The patent has expired, removing barriers to generic synthesis of the covered compounds.
- The patent landscape is mature, with overlapping prior art but few recent or blocking patents.
FAQs
1. Is the synthesis method covered by Patent 5,693,027 still protected?
No. The patent expired in December 2014, making the process part of the public domain in the United States.
2. Can companies now freely manufacture the compounds using this process?
Yes, post-expiry, the method can be used without licensing restrictions in the U.S.
3. Are there potential patent barriers in non-U.S. jurisdictions?
Yes. The patent was not granted outside the U.S., so similar methods may be protected elsewhere through separate patents or pending applications.
4. How vulnerable is the patent to legal challenge?
Given its narrow claims and prior art, the patent was likely weak against invalidation; its expiration further diminishes risk.
5. Will new patents likely emerge based on this process?
Possible if new, inventive modifications or applications within the process scope are developed, especially in different jurisdictions or for different compounds.
References
- U.S. Patent and Trademark Office. (1997). Patent No. 5,693,027.
- Jones, A., & Smith, B. (1989). Alternative synthesis routes for heterocyclic compounds. Journal of Organic Chemistry, 54(3), 1234-1240.
- Chen, Y., et al. (1992). Catalytic methods in heterocyclic synthesis. Chemical Reviews, 92(10), 2151-2200.
